Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
the bull case· 3
13
disclosed supplier and customer ties in SEC filings
sec filingsedgar+7.61%
change in shares held by the ten largest reporting managers over latest quarter
13fJun 30 '263
of the funds on file reporting a position in QTRX
n-portas of Jun 30 '26the bear case· 3
6 of 8
recent reports where the move came in under the options implied range
earnings historyimplied vs realized9 of 21
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '260.01%
of iShares Russell two thousand ETF assets the largest fund weight on file
n-portJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 17 '26 report. Not a forecast, not advice.
Of the 6 companies Quanterix Corp moves with most closely, 2 also share its SEC classification.
Measured against 500 trading days of our own closes. Co-movement, not cause.
SIC 3826, Laboratory Analytical Instruments, from each company's own filings. Largest first.
A rule beside a ticker marks a company that appears in both readings.
Which of these the filings never mention ›tall tick = annual report · 1 on record
132 managers report a position worth $128.3M between them, and 19 of them hold 80% of it.
QTRX (Quanterix Corp) has 12 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
Quanterix Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Laboratory Analytical Instruments
High 3.12 at 9:30 am ET, low 3.01 at 3:00 pm ET.